Y. Bang

HER2-positive advanced gastric cancer: similar HER2-positivity levels to breast cancer

Florian Lordick, Y. Bang, Y-K. Kang et al. · mediaTUM (Technical University of Munich) · 2007 · 31 citations

Breast Oncology, Gastrointestinal Oncology, Similar Her2-positivity Levels +8

HER2-positivity rates in advanced gastric cancer (GC): Results from a large international phase III trial

Y. Bang, HC Chung, Akira Sawaki et al. · Journal of Clinical Oncology · 2008 · 23 citations

Advanced Gastric Cancer, Cancer Management, Gastroenterology +17

3541 POSTER HER2-positive advanced gastric cancer: similar HER2-positivity levels to breast cancer

Florian Lordick, Y. Bang, Yookija Kang et al. · European Journal of Cancer Supplements · 2007 · 15 citations

Poster Her2-positive, Breast Oncology, Gastrointestinal Oncology +11

Phase III, Randomized, Double-blind Trial of Sunitinib Versus Placebo in Patients With Progressive, Well-differentiated Pancreatic Islet Cell Tumours

Éric Raymond, Ivan Borbath, Jean‐Luc Raoul et al. · DIAL (Catholic University of Leuven) · 2009 · 11 citations

Pancreatic Cancer, Sunitinib Versus Placebo, Medicine +8

Phase 1 study of ramucirumab (R) plus durvalumab (D) in patients (pts) with locally advanced and unresectable or metastatic gastrointestinal or thoracic malignancies (NCT02572687); Phase 1a results

C.-C. Lin, Talia Golan, J. Corral et al. · Annals of Oncology · 2016 · 10 citations